Financial Analysis: Caladrius Biosciences (CLBS) & DaVita (DVA)
DaVita (NYSE: DVA) and Caladrius Biosciences (NASDAQ:CLBS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings. Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter. Given Caladrius Biosciences’ stronger consensus rating and higher possible upside, analysts plainly believe Caladrius Biosciences is more favorable than DaVita.